Abstract
Constitutive Kras and NF-κB activation is identified as signature alterations in pancreatic ductal adenocarcinoma (PDAC). However, how NF-κB is activated in PDAC is not yet understood. Here, we report that pancreas-targeted IKK2/β inactivation inhibited NF-κB activation and PDAC development in Kras G12D and Kras G12D;Ink4a/Arf F/F mice, demonstrating a mechanistic link between IKK2/β and Kras G12D in PDAC inception. Our findings reveal that Kras G12D-activated AP-1 induces IL-1α, which, in turn, activates NF-κB and its target genes IL-1α and p62, to initiate IL-1α/p62 feedforward loops for inducing and sustaining NF-κB activity. Furthermore, IL-1α overexpression correlates with Kras mutation, NF-κB activity, and poor survival in PDAC patients. Therefore, our findings demonstrate the mechanism by which IKK2/β/NF-κB is activated by Kras G12D through dual feedforward loops of IL-1α/p62. © 2012 Elsevier Inc.
Original language | English |
---|---|
Pages (from-to) | 105-120 |
Number of pages | 15 |
Journal | Cancer Cell |
Volume | 21 |
Issue number | 1 |
DOIs | |
Publication status | Published - 17 Jan 2012 |